Developer docs
API playgroundTry for free, no card

Search company profiles

Health Logic Interactive

Full company profile

uuid000yr4z

Namestring
Health Logic Interactive
Websiteurl
healthlogicinteractive.com
Company typeenum
Private
Founded yearint
2007
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersCalgary, Canada
HQ citystring
Calgary
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
consumer diagnostics, point-of-care testing, handheld medical devices, cardiovascular health monitoring, kidney disease diagnostics
Industry3 codes
1Remote Diagnostics & Point-of-Care (Connected Testing, Home Lab Devices)
CodeHLACAPAKPrimaryYes
2Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers)
CodeHLAHACALPrimaryNo
3Medical-Grade Device Connectivity & Device Management (MDM)
CodeHLACAFAGPrimaryNo
NAICS code1 code
  • Medical and Diagnostic Laboratories62151
SIC code2 codes
  • In Vitro & In Vivo Diagnostic Substances2835
  • Surgical & Medical Instruments & Apparatus3841
Product category
Consumer Point-of-Care Diagnostics
Social media profiles1 record
Cost components4 values
Technology or R&D, Personnel, Supply Chain, Operations
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Health Logic Interactive is developing and commercializing consumer-focused handheld point-of-care diagnostic devices intended for personal health monitoring. The company is building a platform of portable diagnostic tools targeting areas such as cardiovascular and kidney health, combining clinical-grade measurement with consumer usability. Its work also extends into risk-assessment assets such as the Kidney Failure Risk acquisition made in 2021.

Differentiator
Functional benefit
Problem solved
Recent move3 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
1Binx Health
TypeEmerging player
Description

Binx Health offers molecular diagnostics at the point of care with a connected reader-plus-cartridge platform, sharing Health Logic Interactive's connected-handheld architecture and decentralized testing positioning.

2Becton, Dickinson and Company (BD)
TypeBroad incumbent
Description

BD's Diagnostics segment includes rapid point-of-care and at-home test offerings as part of a much broader med-tech portfolio. It is a broad incumbent whose regulatory, manufacturing, and distribution scale raises the barrier for new entrants.

3Siemens Healthineers
TypeBroad incumbent
Description

Siemens Healthineers operates a global diagnostics franchise including POC platforms. It is a broad incumbent providing scale, regulatory, and channel context for evaluating Health Logic Interactive's competitive position.

4LumiraDx
TypeDirect peer
Description

LumiraDx developed a connected handheld POC diagnostic platform combining microfluidic test strips with a reader and cloud software — a near-direct product architecture analog to Health Logic Interactive's stated approach.

5Everlywell
TypeEmerging player
Description

Everlywell is a consumer-direct diagnostics brand spanning at-home sample collection and connected testing experiences. It represents the consumer-channel and brand-driven side of the market Health Logic Interactive is targeting.

6Atomo Diagnostics
TypeEmerging player
Description

Atomo Diagnostics is an emerging player focused on integrated rapid diagnostic test devices for infectious disease and chronic conditions — overlapping with Health Logic Interactive's handheld consumer POC thesis at an early commercialization stage.

7Roche Diagnostics
TypeBroad incumbent
Description

Roche is a global diagnostics leader with deep POC and consumer-adjacent capabilities. Its breadth and clinical-evidence base make it a key reference comparable for product credibility and competitive dynamics.

8Cue Health
TypeDirect peer
Description

Cue Health builds consumer-targeted handheld molecular diagnostic readers connected to a data platform. It is the closest direct comparable to Health Logic Interactive's stated handheld POC diagnostic device focus.

9QuidelOrtho
TypeBroad incumbent
Description

QuidelOrtho is a major diagnostics platform with rapid point-of-care and consumer-adjacent test products. It represents the kind of scaled incumbent Health Logic Interactive would compete against for shelf space and clinical adoption.

10Abbott
TypeBroad incumbent
Description

Abbott is a global diagnostics leader with consumer-facing rapid and at-home test products (Binax, iHealth). It is a broad incumbent shaping the competitive landscape for any new consumer POC device entrant.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat2 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights4 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Health Logic Interactive

Consumer Point-of-Care Diagnosticshealthlogicinteractive.com

Health Logic Interactive firmographics

Firmographics
Name
Health Logic Interactive
Website
https://healthlogicinteractive.com
Company type
Private
Founded year
2007
Operating status
Operating
Headcount range
1–10 employees
Ownership category
akta.pro rank

Health Logic Interactive industry classification

Industry
Product category
Consumer Point-of-Care Diagnostics
NAICS
Medical and Diagnostic Laboratories (62151)
SIC
In Vitro & In Vivo Diagnostic Substances (2835), Surgical & Medical Instruments & Apparatus (3841)
akta.pro primary industry
Remote Diagnostics & Point-of-Care (Connected Testing, Home Lab Devices) (HLACAPAK)
akta.pro secondary industries
Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers) (HLAHACAL), Medical-Grade Device Connectivity & Device Management (MDM) (HLACAFAG)

Keywords

  • Consumer diagnostics
  • Point-of-care testing
  • Handheld medical devices
  • Cardiovascular health monitoring
  • Kidney disease diagnostics

Where Health Logic Interactive is headquartered

Location

Headquarters

HQ city
Calgary
HQ country
Canada
HQ region
North America

Markets served

Health Logic Interactive business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Supply Chain, Operations

Health Logic Interactive product offering

Product offering

Core offering

Health Logic Interactive is developing and commercializing consumer-focused handheld point-of-care diagnostic devices intended for personal health monitoring. The company is building a platform of portable diagnostic tools targeting areas such as cardiovascular and kidney health, combining clinical-grade measurement with consumer usability. Its work also extends into risk-assessment assets such as the Kidney Failure Risk acquisition made in 2021.

Differentiator

Problem solved

Functional benefit

Companies that use Health Logic Interactive

Customer profile

Ideal customer profiles1 record

Health Logic Interactive technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Health Logic Interactive partnerships and signals

Strategic signal

Recent moves3 records

Expansion highlights4 records

Health Logic Interactive competitors and assessment

Company assessment

Emerging players

  • Binx Health: Binx Health offers molecular diagnostics at the point of care with a connected reader-plus-cartridge platform, sharing Health Logic Interactive's connected-handheld architecture and decentralized testing positioning.
  • Everlywell: Everlywell is a consumer-direct diagnostics brand spanning at-home sample collection and connected testing experiences. It represents the consumer-channel and brand-driven side of the market Health Logic Interactive is targeting.
  • Atomo Diagnostics: Atomo Diagnostics is an emerging player focused on integrated rapid diagnostic test devices for infectious disease and chronic conditions — overlapping with Health Logic Interactive's handheld consumer POC thesis at an early commercialization stage.

Broad incumbents

  • Becton, Dickinson and Company (BD): BD's Diagnostics segment includes rapid point-of-care and at-home test offerings as part of a much broader med-tech portfolio. It is a broad incumbent whose regulatory, manufacturing, and distribution scale raises the barrier for new entrants.
  • Siemens Healthineers: Siemens Healthineers operates a global diagnostics franchise including POC platforms. It is a broad incumbent providing scale, regulatory, and channel context for evaluating Health Logic Interactive's competitive position.
  • Roche Diagnostics: Roche is a global diagnostics leader with deep POC and consumer-adjacent capabilities. Its breadth and clinical-evidence base make it a key reference comparable for product credibility and competitive dynamics.
  • QuidelOrtho: QuidelOrtho is a major diagnostics platform with rapid point-of-care and consumer-adjacent test products. It represents the kind of scaled incumbent Health Logic Interactive would compete against for shelf space and clinical adoption.
  • Abbott: Abbott is a global diagnostics leader with consumer-facing rapid and at-home test products (Binax, iHealth). It is a broad incumbent shaping the competitive landscape for any new consumer POC device entrant.

Direct peers

  • LumiraDx: LumiraDx developed a connected handheld POC diagnostic platform combining microfluidic test strips with a reader and cloud software — a near-direct product architecture analog to Health Logic Interactive's stated approach.
  • Cue Health: Cue Health builds consumer-targeted handheld molecular diagnostic readers connected to a data platform. It is the closest direct comparable to Health Logic Interactive's stated handheld POC diagnostic device focus.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights4 records

Customer concentration

Health Logic Interactive social profiles

Digital presence

Health Logic Interactive financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Health Logic Interactive leadership team

Management profile

Number of profiles

Profiles2 records

Health Logic Interactive funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Health Logic Interactive M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Health Logic Interactive

What does Health Logic Interactive do?

Health Logic Interactive is developing and commercializing consumer-focused handheld point-of-care diagnostic devices intended for personal health monitoring. The company is building a platform of portable diagnostic tools targeting areas such as cardiovascular and kidney health, combining clinical-grade measurement with consumer usability. Its work also extends into risk-assessment assets such as the Kidney Failure Risk acquisition made in 2021.

When was Health Logic Interactive founded?

Health Logic Interactive was founded in 2007. It employs 1 to 10 people.

Where is Health Logic Interactive based?

Health Logic Interactive is headquartered in Calgary, Canada, in the North America region.

Who are Health Logic Interactive's main competitors?

Emerging players on record are Binx Health, Everlywell and Atomo Diagnostics. Broad incumbents are Becton, Dickinson and Company (BD), Siemens Healthineers, Roche Diagnostics, QuidelOrtho and Abbott. Direct peers are LumiraDx and Cue Health.

Does Health Logic Interactive have an API?

No public API is recorded for Health Logic Interactive.

What industry is Health Logic Interactive in?

Health Logic Interactive's product category is Consumer Point-of-Care Diagnostics. Its primary akta.pro industry code is HLACAPAK, Remote Diagnostics & Point-of-Care (Connected Testing, Home Lab Devices), with a secondary code of HLAHACAL, Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers). Its NAICS code is 62151 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireHealth Logic Interactive Signs Non-Binding Letter of Intent With US Medical Device Company to Sell Wholly Owned Operating SubsidiaryHealth Logic Interactive Inc. signed a non-binding letter of intent on August 1, 2021, to sell its wholly owned operating subsidiary, My Health Logic Inc., to Nevada-based medical device company Marizyme, Inc. The transaction would see Health Logic receive 4,600,000 Marizyme common shares as consideration, subject to due diligence, TSX Venture Exchange approval, shareholder approval, and negotiation of definitive documentation. Marizyme, whose flagship product DuraGraft® is approved in 34 countries and under FDA pre-submission review, intends to pursue a NASDAQ listing within twelve months and has indicated plans to raise operating capital for the combined businesses following close.PR NewswireHealth Logic Interactive Provides Update on Anticipated Pre-Submission Meeting with FDA for MATLOC 1Health Logic Interactive Inc. announced continued progress toward a pre-submission meeting with the FDA for its MATLOC 1 diagnostic screening device, anticipated to occur in September 2021. The company has engaged Reveles Clinical Service, a specialty Contract Research Organization based in Southlake, Texas, to provide regulatory strategy and clinical trial management support in preparation for the meeting. The CEO stated that the company expects the meeting to help de-risk the regulatory pathway and provide clarity necessary for a successful 510(k) application.PR NewswireHealth Logic Interactive Provides Product Update for MATLOC 1 Digital Diagnostic DeviceHealth Logic Interactive Inc. announced an update on the development of its MATLOC 1 digital diagnostic device, a proprietary platform designed to test biomarkers including albumin and creatinine for chronic kidney disease screening. The company reported that its optical measurement functional sub-system has been built and is generating data, while a fluid handling sub-system has also been created and tested, with design work on a urine sampling cartridge ongoing. The company stated it continues to advance toward integration of MATLOC 1 with its lab-on-chip technology and an expected submission to the United States Food and Drug Administration.PR NewswireHealth Logic Interactive Receives Letter of Support from the Director of the Kidney and Blood Pressure Center at Tufts Medical CenterHealth Logic Interactive Inc.'s wholly-owned subsidiary My Health Logic received a letter of support from Dr. Lesley A. Inker, Director of the Kidney and Blood Pressure Center at Tufts Medical Center and member of the company's scientific advisory board, for its chronic kidney disease lab-on-chip technology. Dr. Inker stated the device represents a major innovation in CKD prevention that could be transformative for patient care by enabling easy access to kidney function measurements at home or at point of care. The company cited CDC data indicating more than 1 in 7 US adults have CKD, with as many as 9 in 10 unaware they carry the disease, highlighting what Health Logic sees as a significant testing gap its technology could address.PR NewswireHealth Logic Interactive Announces Proof-of-Concept Test Results and Advancement of its Lab-on-Chip TechnologyHealth Logic Interactive announced positive preliminary proof-of-concept test results for its urine creatinine chip prototype (uC-Chip beta version), successfully validating a clinically relevant detection range. The company is simultaneously advancing development of an integrated urine albumin-to-creatinine ratio chip (uACR-Chip) and preparing for a pre-submission meeting with the US FDA as it moves toward commercialization of its lab-on-chip technology for chronic kidney disease detection. The handheld diagnostic devices are designed to connect to patients' smartphones and provide rapid point-of-care testing with data transfer for early kidney disease detection.PR NewswireHealth Logic Interactive Announces Appointment of Scientific Advisory Board Members and First Virtual MeetingHealth Logic Interactive Inc. appointed three nephrology specialists to its Scientific Advisory Board and held the board's first virtual meeting on June 9, 2021. The company stated that this strategic addition is intended to support its pursuit of FDA approval for its MATLOC digital diagnostic device and define its reimbursement strategy for chronic kidney disease testing.PR NewswireHealth Logic Interactive Announces the Establishment of Professorship in Lab-on-Chip Innovations and Grant of OptionsHealth Logic Interactive Inc. announced the establishment of a five-year professorship in lab-on-chip innovations at a Canadian university, funded by annual contributions of $50,000 to advance research and commercialization. Concurrently, the company's board approved the grant of 1,950,000 stock options to directors, employees, and consultants with an exercise price of $0.20.PR NewswireHealth Logic Interactive Receives Letter of Support from the Chief of the Division of Nephrology at Johns Hopkins University School of MedicineHealth Logic Interactive Inc.'s wholly-owned subsidiary My Health Logic received a letter of support from Dr. Chirag R. Parikh, Director of the Division of Nephrology at Johns Hopkins University School of Medicine, for their lab-on-chip device designed for early detection of chronic kidney disease. According to Dr. Parikh, the device could address an unmet need for screening among at-risk patients who lack access to convenient monitoring options. The company, which is listed on the TSXV under the symbol CHIP.H, was also featured in Stat News and expects its technology to eventually seek FDA approval.PR NewswireHealth Logic Interactive Letter to ShareholdersHealth Logic Interactive Inc., based in Calgary, announced its strategic plans to develop innovative point-of-care diagnostic devices for chronic kidney disease, aiming for product release in 2022. The company intends to achieve various milestones over the next few months, including FDA approval and product development collaborations.PR NewswireHealth Logic Interactive Inc., Acquires Next-Generation Lab-On-Chip Medical Diagnostic TechnologyHealth Logic Interactive Inc.'s wholly owned subsidiary My Health Logic Inc. has entered into a worldwide exclusive license agreement for UAL-Chip, a patent-pending lab-on-chip technology enabling rapid point-of-care diagnosis of Chronic Kidney Disease through a smartphone-connected handheld device. The company plans to invest at least $650,000 on product development over the first four years while pursuing regulatory approval via the FDA's accelerated 510(k) pathway. The inventors, a team of nephrologists from Seven Oaks General Hospital and a biomedical engineering expert, are expected to join My Health Logic in leadership positions to advance commercialization.